Costa Rica's Alajuela Municipality Attracts Pharma Companies

---

Researched by Industrial Info Resources (Sugar Land, Texas)--The Alajuela municipality has become one of the preferred destinations for pharmaceutical and life sciences industrial investments in Costa Rica. Industrial Info is tracking more than 30 pharma-biotech projects in the city, representing 20% of investments in the country.

In this way, this city in Costa Rica stands out for offering pharmaceutical hubs with infrastructure and a qualified labor force, a combo that, together with the country's promotion programs and the nearshoring trend make up a whole productive system that is attractive for international companies to start or continue investing in the region. It can mainly be seen in grassroot and expansion projects that mark the pulse of the importance of the region.

The sector that stands out is medical devices, with more than 90% of investments in the sector that Industrial Info is monitoring. The clearest example is Johnson & Johnson's (NYSE:JNJ) (New Brunswick, New Jersey) $600 million grassroot plant for a facility that will produce cardiac and orthopedic devices, which is expected to be completed in 2028. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical-Biotech Project Database can click here for more details on the project.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 trillion (USD).